|
74 Companies |
|
57 Products |
|
57 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
680 News |
|
| «12...234567891011121314» |
- ||| valacyclovir / Generic mfg.
New P3 trial: Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients (clinicaltrials.gov) - May 17, 2012
P3, N=40, Completed, Sponsor: GlaxoSmithKline
- | tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
Enrollment change: Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection (clinicaltrials.gov) - May 16, 2012
P3, N=2900, Recruiting, Sponsor: CONRAD
N=2200 --> 2900
- |||| brilacidin (PMX-30063) / Innovation Pharma
Trial completion: Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus (clinicaltrials.gov) - May 15, 2012
P2, N=215, Completed, Sponsor: PolyMedix, Inc.
N=2200 --> 2900 Recruiting --> Completed
- voriconazole / Generic mfg.
Trial withdrawal: Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects (clinicaltrials.gov) - May 9, 2012
P3, N=0, Withdrawn, Sponsor: Pfizer
Recruiting --> Completed Not yet recruiting --> Withdrawn
- voriconazole / Generic mfg.
Enrollment change: Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects (clinicaltrials.gov) - May 9, 2012
P3, N=0, Withdrawn, Sponsor: Pfizer
Not yet recruiting --> Withdrawn N=60 --> 0
- ||||||| Trial completion: Glizigen-Viudid-External Anogenital Warts in Children and Adolescents (clinicaltrials.gov) - May 5, 2012
P3, N=76, Completed, Sponsor: Catalysis SL
N=60 --> 0 Recruiting --> Completed
- | Trial completion: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients (clinicaltrials.gov) - Apr 24, 2012
P2, N=32, Completed, Sponsor: Foamix Ltd.
Recruiting --> Completed Recruiting --> Completed
- mupirocin / Generic mfg.
Trial completion: SuDS: Staphylococcus Aureus Decolonization Study (clinicaltrials.gov) - Apr 22, 2012
P=N/A, N=183, Completed, Sponsor: Washington University School of Medicine
Recruiting --> Completed Active, not recruiting --> Completed
- Mycamine (micafungin) / Astellas
Trial withdrawal: Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis (clinicaltrials.gov) - Apr 17, 2012
P2, N=0, Withdrawn, Sponsor: University of Arkansas
Active, not recruiting --> Completed Recruiting --> Withdrawn
- Mycamine (micafungin) / Astellas
Enrollment change: Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis (clinicaltrials.gov) - Apr 17, 2012
P2, N=0, Withdrawn, Sponsor: University of Arkansas
Recruiting --> Withdrawn N=70 --> 0
- |||||||||| New P3 trial: Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis (clinicaltrials.gov) - Apr 17, 2012
P3, N=1053, Completed, Sponsor: Taro Pharmaceuticals USA
- ||| clotrimazole topical / Generic mfg.
New P1 trial: Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra (clinicaltrials.gov) - Apr 17, 2012
P1, N=707, Completed, Sponsor: Taro Pharmaceuticals USA
- | Veregen (sinecatechins) / Sinphar Pharma, Medigene
Trial completion: Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers (clinicaltrials.gov) - Apr 17, 2012
P1, N=30, Completed, Sponsor: MediGene
N=70 --> 0 Recruiting --> Completed
- ||| Altabax (retapamulin) / GSK, Almirall
Enrollment change: Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. (clinicaltrials.gov) - Apr 11, 2012
P4, N=60, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed N=87 --> 60
- ||| Ilaris (canakinumab) / Novartis
New P3 trial: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease (clinicaltrials.gov) - Apr 10, 2012
P3, N=15, Recruiting, Sponsor: Novartis Pharmaceuticals
- |||||||||| acyclovir / Generic mfg.
New P3 trial: Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old (clinicaltrials.gov) - Apr 8, 2012
P3, N=51, Completed, Sponsor: Meda Pharmaceuticals
- Trial initiation date: The Role of Genital Warts in HIV Acquisition in Peru (clinicaltrials.gov) - Apr 5, 2012
P=N/A, N=600, Active, not recruiting, Sponsor: University of California, Los Angeles
N=87 --> 60 Initiation date: Oct 2011 --> Apr 2012
- Trial completion: Study of a Cold Sore Patch for the Treatment of Herpes Labialis (clinicaltrials.gov) - Apr 1, 2012
P=N/A, N=472, Completed, Sponsor: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
Initiation date: Oct 2011 --> Apr 2012 Active, not recruiting --> Completed
- Cubicin (daptomycin) / Merck (MSD)
New P4 trial: The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin (clinicaltrials.gov) - Mar 22, 2012
P4, N=20, Not yet recruiting, Sponsor: Hospital Universitario Evangelico de Curitiba
- ||||||| Trial completion: Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections (clinicaltrials.gov) - Mar 21, 2012
P3, N=120, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- valacyclovir / Generic mfg.
Trial completion: Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=30, Completed, Sponsor: University of Toronto
Active, not recruiting --> Completed Recruiting --> Completed
- Trial initiation date: GWprofamilia: Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=342, Completed, Sponsor: La Fundacion para la Investigacion y el Desarrollo
Recruiting --> Completed Initiation date: Apr 2009 --> Dec 2009
- Trial completion: GWprofamilia: Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=342, Completed, Sponsor: La Fundacion para la Investigacion y el Desarrollo
Initiation date: Apr 2009 --> Dec 2009 Not yet recruiting --> Completed
- Kineret (anakinra) / SOBI
New P2 trial: Anakinra in Hidradenitis Suppurativa (clinicaltrials.gov) - Mar 18, 2012
P2, N=20, Active, not recruiting, Sponsor: University of Athens
- New P1 trial: Soft Tissue Ultrasound of Infections (clinicaltrials.gov) - Mar 15, 2012
P1, N=15, Recruiting, Sponsor: Rhode Island Hospital
- | Ossirene (AS101) / Cassiopea, Feramda
New P1/2 trial: Safety and Efficacy Study to Test Topical AS101 for External Genital Warts (clinicaltrials.gov) - Mar 13, 2012
P1/2, N=12, Completed, Sponsor: BioMAS Ltd
- ||||||| Trial completion: Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis (clinicaltrials.gov) - Mar 13, 2012
P3, N=290, Completed, Sponsor: Novartis
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Cubicin (daptomycin) / Merck (MSD)
New P4 trial: Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections (clinicaltrials.gov) - Mar 7, 2012
P4, N=100, Recruiting, Sponsor: University of Cincinnati
- tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
Trial initiation date: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding (clinicaltrials.gov) - Feb 29, 2012
P4, N=55, Recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Feb 2012
- tenofovir vaginal gel (GS-1278 gel) / Gilead, CONRAD
Enrollment open: Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding (clinicaltrials.gov) - Feb 29, 2012
P4, N=55, Recruiting, Sponsor: University of Washington
Initiation date: Nov 2011 --> Feb 2012 Not yet recruiting --> Recruiting
- valacyclovir / Generic mfg.
Trial withdrawal: Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women (clinicaltrials.gov) - Feb 28, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting Terminated --> Withdrawn
- valacyclovir / Generic mfg.
Enrollment change: Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women (clinicaltrials.gov) - Feb 28, 2012
P=N/A, N=0, Withdrawn, Sponsor: University of Pittsburgh
Terminated --> Withdrawn N=1000 --> 0
- New P1/2 trial: Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment (clinicaltrials.gov) - Feb 26, 2012
P1/2, N=30, Recruiting, Sponsor: Chulalongkorn University
- itraconazole / Generic mfg.
Trial completion: ITRACONASP: Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis (clinicaltrials.gov) - Feb 17, 2012
P4, N=31, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
N=1000 --> 0 Recruiting --> Completed
- | Enrollment change: Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen (clinicaltrials.gov) - Feb 12, 2012
P2, N=50, Completed, Sponsor: Nielsen BioSciences, Inc.
Recruiting --> Completed N=36 --> 50
- | teslexivir (BTA074) / Vaxart
New P2a trial: Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts (clinicaltrials.gov) - Feb 12, 2012
P2a, N=24, Recruiting, Sponsor: Anaconda Pharma
- ||||||| Jublia (efinaconazole) / Kaken, Bausch Health
Trial completion: Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis (clinicaltrials.gov) - Feb 5, 2012
P3, N=870, Completed, Sponsor: Dow Pharmaceutical Sciences
N=36 --> 50 Active, not recruiting --> Completed
- ||||||| Jublia (efinaconazole) / Kaken, Bausch Health
Trial completion: The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis (clinicaltrials.gov) - Feb 5, 2012
P3, N=780, Completed, Sponsor: Dow Pharmaceutical Sciences
Active, not recruiting --> Completed Recruiting --> Completed
- New P3 trial: Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis (clinicaltrials.gov) - Jan 31, 2012
P3, N=42, Completed, Sponsor: Prof. Yuen Chun-Wah
- ||||| Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
New P2 trial, P2 data: A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study (clinicaltrials.gov) - Jan 25, 2012
P2, N=200, Completed, Sponsor: Trius Therapeutics, Inc.
- ||||| New P2 trial: A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci (clinicaltrials.gov) - Jan 25, 2012
P2, N=103, Completed, Sponsor: Affinium Pharmaceuticals, Ltd
- ||| New P1 trial: A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis (clinicaltrials.gov) - Jan 25, 2012
P1, N=661, Completed, Sponsor: Taro Pharmaceuticals USA
- Kineret (anakinra) / SOBI
New P2 trial: Anakinra as a Treatment for Hydradenitis Suppurativa (clinicaltrials.gov) - Jan 23, 2012
P2, N=6, Completed, Sponsor: University of California, San Francisco
- ||||| Enrollment change: SHaRCS: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 22, 2012
P3, N=907, Completed, Sponsor: NanoBio Corporation
Recruiting --> Completed N=1600 --> 907
- ||||||| Trial completion: SHaRCS: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (clinicaltrials.gov) - Jan 22, 2012
P3, N=907, Completed, Sponsor: NanoBio Corporation
N=1600 --> 907 Recruiting --> Completed
- ||||||| Naftin (naftifine hydrochloride) / Merz Pharma
Trial completion: Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (clinicaltrials.gov) - Jan 22, 2012
P3, N=860, Completed, Sponsor: Merz Pharmaceuticals, LLC
Recruiting --> Completed Recruiting --> Completed
- ||||||| Naftin (naftifine hydrochloride) / Merz Pharma
Trial completion: Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis (clinicaltrials.gov) - Jan 22, 2012
P3, N=855, Completed, Sponsor: Merz Pharmaceuticals, LLC
Recruiting --> Completed Recruiting --> Completed
- ||| Biomarker, Clinical data, Trial completion: An Observational Study of Fungal Biomarkers (MK-0000-089) (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=116, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| Enrollment change: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) (clinicaltrials.gov) - Jan 16, 2012
P3, N=847, Completed, Sponsor: NanoBio Corporation
Active, not recruiting --> Completed N=1600 --> 847
- ||||||| Trial completion: A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) (clinicaltrials.gov) - Jan 16, 2012
P3, N=847, Completed, Sponsor: NanoBio Corporation
N=1600 --> 847 Active, not recruiting --> Completed